Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Alnylam Pharmaceuticals Inc shares valued at $465,772 were sold by Fitzgerald Kevin Joseph on Mar 03 ’25. At $243.73 per share, Fitzgerald Kevin Joseph sold 1,911 shares. The insider’s holdings dropped to 14,345 shares worth approximately $3.56 million following the completion of this transaction.
Also, Fitzgerald Kevin Joseph sold 844 shares, netting a total of over 203,532 in proceeds. Following the sale of shares at $241.15 each, the insider now holds 13,501 shares.
Before that, Tanguler Tolga had sold 471 shares from its account. In a trade valued at $114,820, the EVP, Chief Commercial Officer traded Alnylam Pharmaceuticals Inc shares for $243.78 each. Upon closing the transaction, the insider’s holdings decreased to 471 shares, worth approximately $6.95 million.
As published in a research note from Wolfe Research on November 12, 2024, Alnylam Pharmaceuticals Inc [ALNY] has been rated down from a Peer perform to an Underperform. Analysts at Scotiabank started covering the stock with ‘”a Sector outperform”‘ outlook in a report released in mid October. As of August 16, 2024, Goldman has increased its “Neutral” rating to a “Buy” for ALNY. Earlier on February 16, 2024, Goldman downgraded its rating. Their new recommendation was “a Neutral” for ALNY stock which previously was a “a Buy”.
Analyzing ALNY Stock Performance
During the last five days, there has been a surge of approximately 4.65%. Over the course of the year, Alnylam Pharmaceuticals Inc shares have jumped approximately 5.45%. Shares of the company reached a 52-week high of $287.22 on 01/27/25 and a 52-week low of $231.00 on 01/06/25. A 50-day SMA is recorded $254.44, while a 200-day SMA reached $247.01.
Support And Resistance Levels for Alnylam Pharmaceuticals Inc (ALNY)
According to the 24-hour chart, there is a support level at 244.19, which, if violated, would cause prices to drop to 240.24. In the upper region, resistance lies at 252.46. The next price resistance is at 256.78. RSI (Relative Strength Index) is 44.69 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.68, which suggests the price will decrease in the coming days. Percent R is at 59.01%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
